You have 9 free searches left this month | for more free features.

City

Condition

Recurrent Ovarian Cancer (1)

Overall Status

Approved for marketing (1)

Sign in for free

Phase

Sponsor

Tesaro, Inc. (1)

Collaborator

Intervention

niraparib (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Expanded Access (1)

TOPACIO

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recurrent Ovarian Cancer Trial (Niraparib)

Approved for marketing

Recurrent Ovarian Cancer

Niraparib

(no location specified)

Apr 13, 2017